Adalimumab-induced asthma.

Bronchospasm associated with anti-TNF treatment. Clin Rheumatol (2009) 0.81

Sinusitis: a possible link with adalimumab. Clin Rheumatol (2008) 0.75

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65

Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet (1981) 6.62

Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51

Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82

Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol (1998) 3.51

Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA (1997) 3.24

The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol (1988) 3.05

Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01

Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol (1982) 2.86

Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth (2009) 2.83

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51

The 5'-proximal region of the wheat Cab-1 gene contains a 268-bp enhancer-like sequence for phytochrome response. EMBO J (1987) 2.31

One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18

Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol (1980) 2.16

Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology (2000) 2.09

Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr (1976) 2.00

Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93

Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation (1981) 1.88

Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol (1992) 1.83

Phytochrome activation of two nuclear genes requires cytoplasmic protein synthesis. EMBO J (1989) 1.81

HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol (1984) 1.79

Targeted therapies in rheumatoid arthritis: the need for action. Rheumatology (Oxford) (1999) 1.78

Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75

Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. Clin Exp Immunol (1982) 1.75

Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest (2001) 1.73

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann Rheum Dis (2012) 1.67

The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc Natl Acad Sci U S A (1991) 1.67

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Br J Dermatol (2004) 1.61

The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis. Clin Exp Immunol (1983) 1.56

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology (2006) 1.56

Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow. Arch Biochem Biophys (1999) 1.56

Abnormal homicide in Hong Kong. Br J Psychiatry (1973) 1.50

Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol (1987) 1.47

Experiences in religious psychotherapy. Aust N Z J Psychiatry (1997) 1.39

Clinical associations of anti-lamin autoantibodies. Aust N Z J Med (1996) 1.39

Ring chromosome 14: a distinct clinical entity. J Med Genet (1981) 1.39

Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias. Am Heart J (1996) 1.38

Rifampicin antibiotic impregnation of the St. Jude Medical mechanical valve sewing ring: a weapon against endocarditis. J Thorac Cardiovasc Surg (1996) 1.38

Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell (1997) 1.37

Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin Exp Immunol (2000) 1.35

Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis (2010) 1.34

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann Rheum Dis (2008) 1.31

5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol (2000) 1.31

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res (2000) 1.30

Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ Health Perspect (1990) 1.24

Upper gastrointestinal endoscopy performed by nurses: scope for the future? Gut (2003) 1.23

Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene (1999) 1.22

Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery (2000) 1.22

Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid. Ann Rheum Dis (1974) 1.21

Patterns of onset and cessation of drug use over the early part of the life course. Health Educ Behav (1997) 1.21

The management of compound leg injuries in the West Midlands (UK): are we meeting current guidelines? Br J Plast Surg (2005) 1.21

Surface and subsurface morphology of bovine humeral articular cartilage as assessed by atomic force and transmission electron microscopy. J Struct Biol (1997) 1.20

Expression of murine 21-hydroxylase in mouse adrenal glands and in transfected Y1 adrenocortical tumor cells. Proc Natl Acad Sci U S A (1985) 1.20

Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N Z J Med (1995) 1.18

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther (2007) 1.18

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. Ann Rheum Dis (2011) 1.17

Collagen in the egg shell membranes of the hen. Dev Biol (1984) 1.16

Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis (1984) 1.16

Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am J Physiol (1997) 1.15

Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis (2011) 1.15

Sacroiliitis presenting as sciatica. Rheumatology (Oxford) (2005) 1.14

The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer (2003) 1.14

Congenital coronary artery aneurysms. Br Heart J (1974) 1.13

The role of mechanical loading histories in the development of diarthrodial joints. J Orthop Res (1988) 1.13

Macrosocial and environmental influences on minority health. Health Psychol (1995) 1.12

Chloroquine as a probe for antigen processing by accessory cells. Transplantation (1982) 1.11

Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb (1991) 1.11

Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics. J Thorac Cardiovasc Surg (1995) 1.10

Aggregation of dipalmitoylphosphatidylcholine vesicles. Biochemistry (1982) 1.10

Musculoskeletal ontogeny, phylogeny, and functional adaptation. J Biomech (1991) 1.10

A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T proliferative responses to various antigens. J Immunol (1984) 1.09

Differential effects of embryonic immobilization on the development of fibrocartilaginous skeletal elements. J Rehabil Res Dev (2000) 1.08

Late-onset infections of infants in neonatal units. J Paediatr Child Health (1996) 1.08

Virus--cell interaction: prediction of the time course of observable effects from virus interaction at cell injection sites, and mechanisms leading to attachment. FEBS Lett (1978) 1.07

Candida dubliniensis at a cancer center. Clin Infect Dis (2001) 1.06

Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation (1985) 1.05

Web-based telemicroscopy. J Struct Biol (1999) 1.05

Importance of the superficial tissue layer for the indentation stiffness of articular cartilage. Med Eng Phys (2002) 1.05

School performance, nutritional status and trichuriasis in Jamaican schoolchildren. Acta Paediatr (1994) 1.04

Detection of Goodpasture antigen in fractions prepared from collagenase digests of human glomerular basement membrane. Clin Exp Immunol (1984) 1.04

Mycobacterium genavense infections in pet animals. J Clin Microbiol (1996) 1.02

Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum (1990) 1.02

Growth of Plasmodium falciparum in human erythrocytes containing abnormal membrane proteins. Proc Natl Acad Sci U S A (1990) 1.02

Characterization of poly(ADP-ribose)--histone H1 complex formation in purified polynucleosomes and chromatin. Eur J Biochem (1980) 1.01

Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure. Rheumatology (Oxford) (2005) 1.01

Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res (1997) 1.01

Rosai-Dorfman disease of the testis: an unusual entity that mimics testicular malignancy. J Clin Pathol (2006) 1.00

Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol (1997) 1.00

p27Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res (2001) 0.99

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo. Nat Biotechnol (2000) 0.99

Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. Rheumatology (Oxford) (2005) 0.99

Size and motion of the mitral valve annulus in man. II. Abnormalities in mitral valve prolapse. Circulation (1982) 0.99

A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions. Arch Dis Child (2006) 0.98